FDA Investigator Yvonne C Wilkes

Yvonne C Wilkes has conducted inspections on 354 sites in 1 countries as of 26 Oct 2022. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
354
Last Inspection Date:
26 Oct 2022
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Yvonne C Wilkes:
Abby Lmozeke Baker, Adam J Taylor, Alexander M Kay, Alexandra B Pitkin, Amalia C Himaya, Amy A Johnson, Amy Wyan Mai, Ana Djurdjevic, Ana S Cabrera, Anderson, Andrew K Haack, PhD, Andy B Lee, Angel K Sandhu, Angelina M Albert, Anita Narula, PhD, Annette Melendez, April P Shaw, Armando Chavez, MS, Arsen Karapetyan, Barbara G Peoples, Barry Cherney, PhD, Beverly A Thomas, Bichsa T Tran, Bo Chi, PhD, Brentley S Collins, Brian P Putz, Brien C Fox, Bryce A May, Carla J Lundi, Carol B Czerniak, Caryn M Mcnab, Celeta S Coves, Charles D Boison, Charles L Larson, Cheron M Portee, Christina C Santos, Christina V Santos, Colleen M Aspinwall, Comyar Shoghi, Courtney N Long, Creighton T Tuzon, Daniel J Lahar, Daniel W Cline, Darla J Christopher, Davinna Ligons, PhD, Davis, Deborah A Greco, Dennis M Farley, Diana L Ayala, Diana M Rand, Diane Cvan Leeuwen, Doan T Nguyen, PharmD, Don A Leeseberg, Donna Ltartaglino Besone, Donna Mwilliams Hill, PhD, Doretha M Tonkins, Doretha M Wilson, Dyana K Stone, Dylan R Jock, Emily B Camire, Emily S Mcgann, Eric Zhu, Esther C Broner, PhD, Firasat H Ghori, Frances Namuswe, PhD, Gabriel M Guevarra, Gail L Katz, Garrad R Poole, Gene D Arcy, Gerald T O'connor, Grace P Santos, Haley H Seymour, Haroon Vohra (NMI), Hasan A Irier, PhD, Herminio C Francisco, Hoimay Chan, Iris C Macinnes, Jaclyn N Munsch, Jacqueline M Bowling, James R Fleckenstein, Janet Pulver, Jee Chung, PhD, Jeffrey P Raimondi, Jennifer C Adams, Jennifer C Johnson, Jennifer Gogley, Jennifer L Custodio, Jennifer M Foley, Jennifer M Gogley, Jinnie Kokiatkulkij, Jocelyn E Massey, Joel Welch, PhD, John A Iwen, John L Stevens, John R Myung, Joseph C Yen, Joshua S Hoeh, Julian C Hanson, Junho Pak, Ka L Wong, Karen J Bak, Kathleen B Swat, Kathleen R Jones, PhD, Kelvin Cheung, Kelvin X Sanders, Kendra A Biddick, Kenneth S Boehnen, Kim Lthomas Cruse, Kimberly M Lichter, Lakecha N Lewis, Laura E Garcia, Laura Fontan, MS, Lauren E Swantko, Lauren M Lilly, PhD, Laurie A Haxel, Laurissa S Flowers, Laverne Kimble, Lawrence H Howell, LCDR Jennifer H Rhyu, Lee Terry Moore, Leonard H Lavi, Linda Thai, Lisa Shin, Lore Fields, Lori J Silverstein, Maida Henesian (NMI), Marcia B Williams, Marcus F Yambot, Mary Ewilkerson Brinsko, Mary R Hole, Matthew J Gretkierewicz, Maurine Fadlalla, Maxyne T Lam, Melissa D Kalik, Melsomar R Ramos, Michael D Garcia, Michael E Cimaglio, Michelle A Marsh, Mihaly S Ligmond, Minh D Phan, Mizanne E Lewis, Mohsen Rajabi Abhari, FDA, Naveen B Walker, Nicholas Obiri, PhD, Nicola M Fenty Stewart, Nikisha M Bolden, Omotunde O Osunsanmi, Paul M Chefor, Peter Kessler, PhD, Peter S Diak, Raymond W Brullo, Rebecca Rodriguez, Richard J Bashay, Richard L Bartlett, Richard T Riggie, Richmond K Yip, Robert D Tollefsen, Robert Darius, Robert M Tillman, Robert S Sweeton, Roger D Gawne, Roger F Zabinski, Roger J Adams, Rona Leblanc, PhD, Ronald L Koller, Ronda Leblanc, Sandra Sejdinovic, Sarah Arden, Sarah Forney, Scott K Zika, Scott R Nichols, PhD, Sean P Desbrow, Seyyida Saterfield, Shaquenta Y Perkins, Shelley H Beausoleil, Sherri J Jackson, Sidney B Priesmeyer, Simone E Pitts, Sonia R Peterson, Sonya L Karsik, RAC, Stanley Au, Steven E Porter, Jr, Steven Fong, MS, PhD, Taichun Qin, PhD, Tamika White, Tania Y Hall, Tawny L Colling, Terrance L Thomas, Terri L Dodds, Terri L Jones, Thanh B Tran, Thanh M Andrews, Thao T Kwan, Thao X Tran, Timothy P Lafave, Tonia L Sawyer, Travis R Hunt, Trushani T Desai, Uttaniti Limchumroon (Tom), Vanessa R Muller, Vashti E Bocker, Vien Q Le, Virgilio F Pacio, CSO, William F Lagud, Jr, Yumi J Hiramine, Yvette E Guillermo, Yvette Mlacour Davis, Yvonne T Lacour

Yvonne C Wilkes's Documents

Publish Date Document Type Title
February, 2001 EIR Amgen, Inc - EIR, 2001-02-23
August, 2021 FDA 483 University Fertility Center - Form 483, 2021-08-10
September, 2008 FDA 483 Hemacare Corp - Form 483, 2008-09-18
August, 2016 EIR Scantibodies Biologics Inc - EIR, 2016-08-17
March, 2015 FDA 483 Banner Desert Medical Center - Form 483, 2015-03-06
October, 2021 FDA 483 Fangyinmeng MD Inc. - Form 483, 2021-10-22
February, 2019 FDA 483 University Fertility Center - Form 483, 2019-02-04
May, 2016 EIR Tissue Banks International Inc - EIR, 2016-05-26
July, 2019 FDA 483 Veterans Affairs Long Beach Health Care System - Form 483, 2019-07-02
June, 2014 FDA 483 Scantibodies Laboratory, Inc. - Form 483, 2014-06-16
December, 2016 EIR Access Biologicals LLC - EIR, 2016-12-14
January, 2018 FDA 483 StemGenex Biologic Laboratories, LLC - Form 483, 2018-01-26
April, 2006 EIR VA GLA Health Care System (WLA) 113 - EIR, 2006-04-04
June, 2022 FDA 483 American Fertility Medical Center - Genetic Infertility & Andrology Laboratory, Inc. - Form 483, 2022-06-09
March, 2015 EIR Banner Desert Medical Center - EIR, 2015-03-06
September, 2022 FDA 483 UCI Medical Center C/O Blood Bank - Form 483, 2022-09-29
July, 2022 FDA 483 Akyut Bayrak, MD. A Professional Corporation - Form 483, 2022-07-21
February, 2001 FDA 483 Amgen, Inc - Form 483, 2001-02-23
June, 2012 FDA 483 Pacific Coast Tissue Bank - Form 483, 2012-06-19
January, 2020 FDA 483 California Fertility Centers, A Medical Corporation - Form 483, 2020-01-24
February, 2019 FDA 483 American Reproductive Centers, Inc. - Form 483, 2019-02-22
May, 2013 FDA 483 Scantibodies Laboratory, Inc. - Form 483, 2013-05-24
March, 2022 FDA 483 Incinta Fertility Center, LLC - Form 483, 2022-03-03
March, 2015 FDA 483 Response Banner Desert Medical Center - Form 483R, 2015-03-08
November, 2016 EIR Brooks Life Sciences - EIR, 2016-12-06
December, 2010 EIR HemaCare Corp Dba USC Blood Center - University Village - EIR, 2010-12-20
March, 2020 FDA 483 Lin Fertility Network, Inc. - Form 483, 2020-03-05
June, 2014 EIR Scantibodies Laboratory, Inc. - EIR, 2014-06-16
May, 2013 EIR Scantibodies Laboratory, Inc. - EIR, 2013-05-24
November, 2019 FDA 483 University Fertility Center - Form 483, 2019-11-26

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more